Search for: "BIOTECH, INC." Results 141 - 160 of 1,249
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 May 2019, 2:14 pm by Astarita
Steven Burrill for misappropriating more than $4 million from their San Francisco-based biotech venture capital fund“I am pleased that Erin has agreed to take on the important role of leading the talented and dedicated group of women and men in our San Francisco Regional Office,” said SEC Chairman Jay Clayton. [read post]
15 Apr 2019, 5:43 am by Tim Curtis
Baltimore-biotech firm Paragon Bioservices has been acquired by the New Jersey-based drug manufacturer Catalent, Inc., for $1.2 billion, Paragon announced Monday. [read post]
31 Jan 2019, 1:15 pm by Zachary Silbersher
Janssen Biotech, Inc., No. 16-221 (LPS) (Dkt. 471) (Jan. 25, 2019), invalidated broad antibody patents for not being sufficiently enabled, as well as coming near to invalidating the same patents for lacking written description. [read post]
25 Jan 2019, 12:00 am by David Lopez
Sage Therapeutics, Inc. was one of those companies who amid all the oncology talk at the conference, shocked the biotech industry with reports of a new drug that significantly helped patients suffering from postpartum depression. [read post]
27 Dec 2018, 8:42 pm by Patent Docs
District Court Judge Susan Illston stuck again on Christmas Eve, giving the biotech patent community a rhetorical lump of coal in their stocking by invalidating on summary judgment claims directed to methods for isolating cell-free fetal DNA from maternal DNA on the grounds that they are not patent-eligible under 35 U.S.C. [read post]
30 Nov 2018, 6:43 am by David Jensen
It is all about a financial "valley of death" that can imperil biotech firms as they seek to turn research into an actual product that can be used by patients. [read post]
6 Nov 2018, 9:51 am by David Jensen
 The firm is Poseida Therapeutics, Inc., which is testing the safety of a therapy for a type of blood cancer in a phase one clinical trial. [read post]
24 Oct 2018, 9:16 am by Lawrence B. Ebert
To demonstratepossession, the inventor must provide enoughdescription in the specification to demonstrate that heactually invented what has been claimed—a “mere wishor plan for obtaining the claimed invention” is not enough.Centrocor Ortho Biotech, Inc. v. [read post]
10 Sep 2018, 12:59 pm by Renae Lloyd
According to reports, Miami biotech billionaire Phillip Frost allegedly participated in two of these three schemes. [read post]
7 Sep 2018, 10:24 am
Ford, Alpha Capital Anstalt, ATG Capital LLC, GRQ Consultants Inc., HS Contrarian Investments LLC, Grander Holdings Inc., Melechdavid Inc., OPKO Health Inc., Frost Gamma Investments Trust, Southern Biotech Inc., and Stetson Capital Investments Inc. with violating antifraud, beneficial ownership disclosure, and registration provisions of the federal securities laws and seeks monetary and equitable... [read post]
3 Sep 2018, 9:16 pm by Patent Docs
By Bryan Helwig -- About Life Sciences Court Report: We will periodically report on recently filed biotech and pharma litigation. [read post]
15 Jul 2018, 8:44 pm by Patent Docs
By Bryan Helwig -- About Life Sciences Court Report: We will periodically report on recently filed biotech and pharma litigation. [read post]
22 Jun 2018, 8:45 am by Beth Mole
Enlarge (credit: Getty | Bloomberg) A small biotech company called Brainstorm Cell Therapeutics Inc. is among the first companies considering selling an experimental therapy directly to patients under the “right to try” measure, signed into law late last month. [read post]